NEW PROSTATE CANCER TREATMENT

Early day motion 1903, tabled 12 July 2007 by Ian Gibson (Labour). Signed by 75 members.

That this House notes that prostate cancer is the most commonly diagnosed cancer in men and causes more than 10,000 deaths each year; laments the fact that men with prostate cancer report a significantly worse experience of treatment and care than patients with other cancers; welcomes the development in the UK of new treatments for men with prostate cancer, such as low dose rate (LDR) prostate brachytherapy, which offers patients improved quality of life after treatment compared with other treatment options; condemns the geographical variations which deny one in six men with prostate cancer in the UK access to this proven therapy; and calls upon the Government to support the work of the Prostate Brachytherapy Advisory Group to maximise patient access to LDR prostate brachytherapy across the whole of the United Kingdom.

Signatures by party: Labour 41, Liberal Democrat 17, Conservative 8, DUP 4, Plaid Cymru 2, Social Democratic and Labour Party 2, Independent 1.